Cancer is a group of diseases driven by inherently nanostructural problems. As such, there are obvious benefits to treatments employing nanoscale structures and processes. Cancer Nanotechnology aims to provide a forum so that the most promising emerging themes should be pre-eminent in the minds of researchers working in one—or, indeed, both—of the disciplines of cancer research or nanotechnology.
Basic, translational and clinical research
Review Submission guidelines
Cancer Nanotechnology conducts an initial suitability assessment of Reviews submitted to the journal to ensure that they are timely, relevant and of a sufficient standard expected of the journal. Authors of Reviews are required to answer the questions on the Review Submission guidelines in their cover letter.
Reviews that do not include this information in the cover letter will not be considered for publication in Cancer Nanotechnology.
Click here to view all the formatting guidelines
Articles
-
-
Evaluation of the performance of Fe3O4/MnO2@doxorubicin hybrid nanozymes on multicellular structure and their therapeutic management to limit the growth of human breast cancer cells
-
A biocompatible nanoformulation of curcumin analogue and curd exosomes targeting EphA2 signalling cascade in head and neck cancer
-
pH-sensitive nanoformulation of acetyl-11-keto-beta-boswellic acid (AKBA) as a potential antiproliferative agent in colon adenocarcinoma (in vitro and in vivo)
-
Enhanced chemotherapy response in hepatocellular carcinoma: synergistic effects of miR-122 and doxorubicin co-delivery system inducing apoptosis and DNA damage
-
Nanomedicine review: clinical developments in liposomal applications
-
Particle therapy and nanomedicine: state of art and research perspectives
-
Biological mechanisms of gold nanoparticle radiosensitization
-
Dye-doped silica nanoparticles: synthesis, surface chemistry and bioapplications
-
Cisplatin-loaded hollow gold nanoparticles for laser-triggered release
Stay up to date
Do you want to stay up to date on the latest from Cancer Nanotechnology? Sign up for article alerts and news from this journal in order to receive updates for recently published articles, as well as news about Cancer Nanotechnology and BMC.
Featured Article
Gujrati et al, Report for the first time the use of bacterial outer membrane vesicles (OMVs) as nanocarriers of cationic dyes for cancer theranostics.
Special article collections
Cancer Nanotechnology publishes special article collections on specific topics. Be sure to take a look at the list of collections we have so far.
We welcome further submissions to these collections.
Alternatively, maybe you have a suggestion for a special collection of your own that you would like to edit. We'd love to hear from you if so!
Latest Tweets
View Twitter timeline
Your browser needs to have JavaScript enabled to view this timeline
Follow
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 4.5
5-year Journal Impact Factor: 5.1
Source Normalized Impact per Paper (SNIP): 0.723
SCImago Journal Rank (SJR): 0.671Speed 2023
Submission to first editorial decision (median days): 6
Submission to acceptance (median days): 93Usage 2023
Downloads: 328,851
Altmetric mentions: 109
- ISSN: 1868-6966 (electronic)
- ISSN: 1868-6958 (print)